Skip to content
Clinical Trials – home
Verifiedinfo

Uniwersyteckie Centrum Kliniczne

Poland Ul. Mariana Smoluchowskiego 17, 80-214 Gdansk, Poland

  • 221 trials recruiting
  • Non-small cell lung cancer · Acute myeloid leukaemia · Plasma cell myeloma
  • Adults and children

About Specializations

Uniwersyteckie Centrum Kliniczne in Gdansk, Poland specialises in clinical trials of conditions such as Non-small cell lung cancer, Acute myeloid leukaemia, Plasma cell myeloma, Non-small cell lung cancer stage IV, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Uniwersyteckie Centrum Kliniczne in Gdansk, research in immune system diseases focuses on conditions such as myasthenia gravis and the prevention of Herpes Zoster in immunocompromised children and adolescents. These studies are designed to better understand treatment response, immune protection, and overall safety in younger patients.

  • Evaluating new treatment options for generalized myasthenia gravis in children and adolescents
  • Studying pediatric Herpes Zoster prevention in immunocompromised patients
  • Assessing immune response and safety in pediatric populations

This area of research supports improved care for children with complex immune-related conditions, with a strong emphasis on therapy effectiveness and protection against infection.

Nervous System Diseases

Clinical trials in nervous system diseases at this site examine relapsing-remitting multiple sclerosis and spinal muscular atrophy, with the goal of improving treatment outcomes for pediatric patients. The work includes efforts to evaluate how well therapies are tolerated and how they affect disease control and functional development.

  • Investigating treatment effects in relapsing-remitting multiple sclerosis
  • Exploring therapy response in spinal muscular atrophy
  • Supporting better disease management in children and adolescents

The research reflects a broad commitment to advancing care in pediatric neurology, especially for conditions that can significantly affect movement, strength, and long-term neurological health.

Musculoskeletal Diseases

Studies in musculoskeletal diseases at Uniwersyteckie Centrum Kliniczne are closely linked to disorders that affect muscle function and physical ability, particularly spinal muscular atrophy and myasthenia gravis. These trials aim to determine whether emerging therapies can improve strength, mobility, and everyday functioning in young patients.

  • Examining therapies for muscle weakness and impaired movement
  • Focusing on functional improvement in spinal muscular atrophy
  • Assessing treatment benefit in myasthenia gravis

This research area helps clarify how new approaches may support better physical outcomes and quality of life for children living with neuromuscular conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Mariana Smoluchowskiego 1780-214 GdanskPoland
Recruiting now
221 trials
Conditions studied
208
Partner status
Verified

More sites in GdanskPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

568 clinical trials

Asthma

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Benralizumab
  • Sponsor:AstraZeneca AB
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Carboplatin
  • Sponsor:BioNTech SE
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:BioNTech SE
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:ZILEBESIRAN
  • Sponsor:Alnylam Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:Alexion Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ruxolitinib
  • Sponsor:Ryvu Therapeutics S.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Povorcitinib
  • Sponsor:Incyte Corp.
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Anastrozole
  • Sponsor:Unicancer
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).